Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination What is the pipeline for future medications for obesity? International Journal of Obesity CagriSema in Adults With or Without Diabetes REDEFINE 1 & 2 Cagrilintide 2.4 mg + Semaglutide 2.4 mg once weekly 20.4% weight loss (non diabetic) & 13.7% (T2D) Tirzepatide vs. Semaglutide: Which GLP 1 Delivers Better Weight Loss? Pura Vida Med Spa Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine